Myeloma Paper of the Day, June 18th, suggested by Robert Orlowski
Robert Orlowski shared on X:
“Myeloma Paper of the Day: Myeloma patients with financial toxicity place more importance on therapy cost, were twice as likely to accept treatment with shorter PFS/lower costs, and African American patients were thrice as likely to report lower willingness to pay.”
Source: Robert Orlowski/X
Financial Toxicity and Willingness-to-Pay for Cancer Treatment Among People With Multiple Myeloma
Author: Mark A. Fiala
Other posts featuring Robert Orlowski on OncoDaily.
Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.
Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.
